<SEC-DOCUMENT>0001104659-18-018350-index.html : 20180316 <SEC-HEADER>0001104659-18-018350.hdr.sgml : 20180316 <ACCEPTANCE-DATETIME>20180316170759 ACCESSION NUMBER: 0001104659-18-018350 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 4 CONFORMED PERIOD OF REPORT: 20180316 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20180316 DATE AS OF CHANGE: 20180316 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Nabriva Therapeutics plc CENTRAL INDEX KEY: 0001641640 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37558 FILM NUMBER: 18696550 BUSINESS ADDRESS: STREET 1: 56 FITZWILLIAM SQUARE CITY: DUBLIN STATE: L2 ZIP: 2 BUSINESS PHONE: (610) 816-6640 MAIL ADDRESS: STREET 1: 1000 CONTINENTAL DRIVE STREET 2: SUITE 600 CITY: KING OF PRUSSIA STATE: PA ZIP: 19406 FORMER COMPANY: FORMER CONFORMED NAME: Nabriva Therapeutics AG DATE OF NAME CHANGE: 20150507 </SEC-HEADER> <DOCUMENT> <TYPE>8-K <SEQUENCE>1 <FILENAME>a18-8436_18k.htm <DESCRIPTION>8-K <TEXT> Document 1 - file: a18-8436_18k.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-1.1 <SEQUENCE>2 <FILENAME>a18-8436_1ex1d1.htm <DESCRIPTION>EX-1.1 <TEXT> Document 2 - file: a18-8436_1ex1d1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>3 <FILENAME>a18-8436_1ex5d1.htm <DESCRIPTION>EX-5.1 <TEXT> Document 3 - file: a18-8436_1ex5d1.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>4 <FILENAME>g84361kii001.gif <DESCRIPTION>GRAPHIC <TEXT> Document 4 - file: g84361kii001.gif
</DOCUMENT> </SEC-DOCUMENT>